DK2376135T3 - USE OF carboxymethylcellulose FOR CONTROL OF UDSPRØJTELIGHED AND clotting OF FORMATIONS CONTAINING ONE OR MORE bioresorbable ceramics - Google Patents

USE OF carboxymethylcellulose FOR CONTROL OF UDSPRØJTELIGHED AND clotting OF FORMATIONS CONTAINING ONE OR MORE bioresorbable ceramics Download PDF

Info

Publication number
DK2376135T3
DK2376135T3 DK09764455.3T DK09764455T DK2376135T3 DK 2376135 T3 DK2376135 T3 DK 2376135T3 DK 09764455 T DK09764455 T DK 09764455T DK 2376135 T3 DK2376135 T3 DK 2376135T3
Authority
DK
Denmark
Prior art keywords
cmc
calcium sulphate
composition
hemihydrate
mpas
Prior art date
Application number
DK09764455.3T
Other languages
Danish (da)
English (en)
Inventor
Niklas Axen
Hans Lennernäs
Anders Carlsson
Lars à Ke Malmsten
Original Assignee
Lidds Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lidds Ab filed Critical Lidds Ab
Application granted granted Critical
Publication of DK2376135T3 publication Critical patent/DK2376135T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/10—Ceramics or glasses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ceramic Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers & Plastics (AREA)
DK09764455.3T 2008-11-27 2009-11-27 USE OF carboxymethylcellulose FOR CONTROL OF UDSPRØJTELIGHED AND clotting OF FORMATIONS CONTAINING ONE OR MORE bioresorbable ceramics DK2376135T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200801674 2008-11-27
PCT/EP2009/008496 WO2010060644A1 (en) 2008-11-27 2009-11-27 Use of carboxymethylcellulose to control ejectability and solidification of time of compositions one or more bioresorbable ceramics

Publications (1)

Publication Number Publication Date
DK2376135T3 true DK2376135T3 (en) 2015-08-31

Family

ID=40823443

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09764455.3T DK2376135T3 (en) 2008-11-27 2009-11-27 USE OF carboxymethylcellulose FOR CONTROL OF UDSPRØJTELIGHED AND clotting OF FORMATIONS CONTAINING ONE OR MORE bioresorbable ceramics

Country Status (14)

Country Link
US (1) US9198884B2 (cg-RX-API-DMAC7.html)
EP (1) EP2376135B1 (cg-RX-API-DMAC7.html)
JP (1) JP5702294B2 (cg-RX-API-DMAC7.html)
KR (1) KR101632430B1 (cg-RX-API-DMAC7.html)
CN (1) CN102227228A (cg-RX-API-DMAC7.html)
AU (1) AU2009319348B2 (cg-RX-API-DMAC7.html)
CA (1) CA2744141C (cg-RX-API-DMAC7.html)
DK (1) DK2376135T3 (cg-RX-API-DMAC7.html)
ES (1) ES2545962T3 (cg-RX-API-DMAC7.html)
IL (1) IL212624A (cg-RX-API-DMAC7.html)
MX (1) MX2011005243A (cg-RX-API-DMAC7.html)
RU (1) RU2536415C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010060644A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201103805B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105727370B (zh) * 2016-02-18 2018-11-06 江苏西宏生物医药有限公司 一种注射植入剂
US11752099B2 (en) 2017-03-27 2023-09-12 W. L. Gore & Associates, Inc. Injectable and biodegradable polymer formulations for controlled release of bioactive agents

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB999487A (en) * 1963-05-03 1965-07-28 Ici Ltd Set-retarded calcium sulphate hemihydrate
US3891453A (en) * 1973-07-26 1975-06-24 United States Gypsum Co Asbestos-free joint compounds
GB1506897A (en) * 1975-11-05 1978-04-12 Ici Ltd Method of securing fixing elements in rock
JPS5626756A (en) * 1979-08-10 1981-03-14 Sato Hironobu Manufacture of alpha gypsum
HU197207B (en) * 1985-12-04 1989-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical comprising 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydro-isoquinolinium-theophylline-7-acetate or its monohydrate as active ingredient
CA2268156C (en) 1996-10-16 2007-05-29 Etex Corporation Bioceramic compositions
JP2000264710A (ja) * 1999-03-23 2000-09-26 Mitsui Chemicals Inc 型材用流し込み組成物
CA2378486A1 (en) 1999-08-05 2001-02-15 Takashi Kurasawa Osteogenesis promoter sustained-release paste
US7371409B2 (en) * 2001-09-06 2008-05-13 Wright Medical Technology, Inc. Bone graft substitute composition
US7291179B2 (en) * 2002-06-24 2007-11-06 Wright Medical Technology, Inc. Bone graft substitute composition
US6652887B1 (en) * 2002-06-24 2003-11-25 Wright Medical Technology, Inc. Bone graft substitute composition
AU2002335562B2 (en) * 2002-09-30 2007-07-05 Regen Biotech, Inc. Bone-filling composition for stimulating bone-forming and bone-consolidation comprising calcium sulfate and viscous biopolymers
WO2004108625A1 (en) * 2003-06-05 2004-12-16 Borden Chemical, Inc. Gypsum products and method for their manufacture
PL1680089T3 (pl) * 2003-10-22 2014-03-31 Lidds Ab Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków
US7671012B2 (en) * 2004-02-10 2010-03-02 Biosurface Engineering Technologies, Inc. Formulations and methods for delivery of growth factor analogs
KR20140014294A (ko) * 2005-03-31 2014-02-05 리드스 에이비 유효 물질의 국소 전달을 기본으로 하는 전립선 질병의 치료 방법
AU2007224651B8 (en) * 2006-03-14 2011-10-27 Lidds Ab Bioresorbable controlled-release composition
DE102008022086A1 (de) * 2008-05-05 2009-11-12 Schulz, Hans H. Zweikomponenten-Alginat

Also Published As

Publication number Publication date
RU2536415C2 (ru) 2014-12-20
RU2011126176A (ru) 2013-01-10
ZA201103805B (en) 2018-11-28
EP2376135A1 (en) 2011-10-19
KR20110102357A (ko) 2011-09-16
CA2744141C (en) 2016-12-13
IL212624A (en) 2017-09-28
MX2011005243A (es) 2011-08-08
IL212624A0 (en) 2011-07-31
CN102227228A (zh) 2011-10-26
HK1168562A1 (en) 2013-01-04
AU2009319348A1 (en) 2010-06-03
AU2009319348B2 (en) 2014-07-31
WO2010060644A1 (en) 2010-06-03
JP2012509919A (ja) 2012-04-26
CA2744141A1 (en) 2010-06-03
EP2376135B1 (en) 2015-05-27
US9198884B2 (en) 2015-12-01
KR101632430B1 (ko) 2016-06-21
JP5702294B2 (ja) 2015-04-15
US20110223214A1 (en) 2011-09-15
ES2545962T3 (es) 2015-09-17

Similar Documents

Publication Publication Date Title
Luo et al. A ready-to-use acidic, brushite-forming calcium phosphate cement
RU2493879C2 (ru) Крупнопористый и хорошо рассасываемый апатитовый кальций-фосфатный цемент
CA2487994C (en) Hydraulic cement based on calcium phosphate for surgical use
JP5279443B2 (ja) ペースト状のポリメチルメタクリレート骨セメント
CA2644429C (en) Bioresorbable controlled-release composition
Smith et al. Incorporation of fast dissolving glucose porogens and poly (lactic-co-glycolic acid) microparticles within calcium phosphate cements for bone tissue regeneration
CN108273141A (zh) 用于防止粘连或止血的医药组合物
CN102049062A (zh) 可注射高效悬浮稳定的磷酸钙骨水泥及其制备方法与应用
CN105339019A (zh) 防粘连材料
CA2744141C (en) Use of carboxymethylcellulose to control ejectability and solidification time of compositions comprising one or more bioresorbable ceramics
EP3144016A1 (en) Inorganic, injectable and thermosensitive cement for bone reconstruction: preparation and use
US8728536B2 (en) Chemotherapeutic composition using nanocrystalline calcium phosphate paste
HK1168562B (en) Use of carboxymethylcellulose to control ejectability and solidification time of compositions comprising one or more bioresorbable ceramics
CN117618656A (zh) 一种含plga载药微粒的多孔羟基磷灰石微球的制备方法及其产品和应用
HK1129061B (en) Bioresorbable controlled-release composition